Priority 3 from the Sight Loss and Vision PSP Cataract
|UNCERTAINTY: How can cataract progression be slowed down? (JLA PSP Priority 3)
|JLA question ID
|No relevant systematic reviews identified at the time of the PSP
|Health Research Classification System category
|Extra information provided by this PSP
|Original uncertainty examples
|This is an indicative uncertainty and was submitted 3 times, and the following submissions were merged to form this uncertainty: How can we slow down cataract progression?
|Systematic reviews in preparation (at the time of PSP)
|Dubois VDJP, Bastawrous A. N-acetylcarnosine (NAC) drops for age-related cataract (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009493. DOI: 10.1002/14651858.CD009493.
|Ongoing controlled trials
|Outcomes to be measured
|Management and or change of symptoms; adverse effects or complications; acceptability to patients or carers; time to return to work or normal activity; time in hospital and or needing health or social care services; health related quality of life; and costs
|PSP unique ID
|Sight Loss and Vision - Cataract
|Total number of uncertainties identified by this PSP.
|42 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|April and May 2013